Two drugs. Two strategies. One industry in the middle of a rewiring.

A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Lately, Pfizer (NYSE: PFE) ...

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

With volatility begetting opportunity, here are all six stocks I've bought through the first five months of 2025. Image ...

A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral proteolysis-targeting chimera ER degrader, vepdegestrant, ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Panaji: A four-year project named Project Parivartan, aiming to reduce hospital-acquired infections and curb antimicrobial resistance, is being implemented in all 41 public health facilities, health ...

A team of international researchers has developed a new biological age “clock” that estimates how well someone is aging, not just how “old” they or their various organs might be. The IC Clock, which ...

Dr. Dinarello has trained over 50 medical investigators, many of whom are recognized as experts in their fields of medicine. The Institute for Science Information has listed Dr. Dinarello as the world ...